May 8, 2019

Raymond W. Ruddon Jr., MD, PhD (1936-2019)

It is with tremendous sadness that we share the news of the passing of Dr. Ray Ruddon on Friday April 26, 2019. Dr. Ruddon was a giant in cancer pharmacology research, in the leadership of our department, and in the philanthropic support of Michigan Pharmacology. Even more than that, he was a stellar human being. We will truly miss him.
From: "Bradford, Carol" <[email protected]>
Date: April 30, 2019 at 11:57:13 AM EDT
To: "'[email protected]'" <[email protected]>
Subject: Passing of Dr. Raymond W. Ruddon, Jr., M.D., Ph.D., Professor Emeritus of Pharmacology    

Dear Colleagues,

It is with great sadness that we share news of the passing of Professor Emeritus of Pharmacology Raymond W. Ruddon, Jr., M.D., Ph.D., on April 26. He was 82.

Dr. Ruddon received his B.S. from the University of Detroit in 1958, and Ph.D. in 1964 and M.D. in 1967 from the University of Michigan. He joined the U-M faculty as an instructor of pharmacology in 1964, and rose through the ranks to professor in 1974.

Dr. Ruddon resigned in 1976 to join the National Cancer Institute, but returned to the U-M in 1981 as professor and chair of the Department of Pharmacology. From 1986-90, he was associate director for basic science research at the Comprehensive Cancer Center. From 1988-90, he also held the title of Maurice H. Seevers Professor of Pharmacology. In 1990, Dr. Ruddon joined the faculty at the University of Nebraska, and in 1997 became the corporate director for science and technology at Johnson and Johnson. He returned to Michigan again in 2004 as professor of pharmacology and senior associate dean for research and graduate studies in the Medical School.

The Board of Regents named Dr. Ruddon Professor Emeritus of Pharmacology in 2006; however, he maintained active emeritus status for many years after his retirement. In 2016, the Medical School established the Raymond and Lynne Ruddon Collegiate Professorship in Cancer Biology and Pharmacology to honor his career and far-reaching contributions to the field.

Dr. Ruddon's research focused on the biosynthesis, assembly, folding and secretion of glycoprotein hormones. His laboratory was the first to demonstrate the folding pathway of a human protein inside an intact cell. He authored more than 100 scientific papers and five books, including the widely used oncology text, Cancer Biology. He was editor of the chemotherapy chapters of the ninth edition of the pharmacology textbook, Goodman and Gilman's The Pharmacological Basis of Therapeutics.

A memorial reception for Dr. Ruddon will be held at the Michigan League, Hussey Room, on May 11 from 3-5:00 p.m.

We send our sincere condolences during this difficult time to Dr. Ruddon’s family, friends, colleagues, trainees, and all who knew him.

Carol R. Bradford, M.D., FACS
Executive Vice Dean for Academic Affairs, U-M Medical School
Chief Academic Officer, Michigan Medicine
Professor of Otolaryngology-Head and Neck Surgery

Lori L. Isom, Ph.D.
Chair, Department of Pharmacology
Maurice H. Seevers Collegiate Professor of Pharmacology
Professor of Pharmacology, Molecular and Integrative Physiology, and Neurology